Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Black Hole Quencher-Enhanced Plasmonic Photothermal Conversion.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

Astragalus polysaccharide-based thermoresponsive hydrogel loaded with β-elemene nanoemulsion in combination with anti-PD-L1 therapy for triple-negative breast cancer.

International journal of biological macromolecules·2026
Same author

2-Aminoadipic Acid mediates the association between BMI and Lipids: Evidence from the CLSA and BHS Cohorts and Mendelian randomization.

American journal of preventive cardiology·2026
Same author

Flavokawain C alleviates dextran sulphate sodium-induced colitis through suppressing necroptosis via blocking RIPK1-RIPK3-MLKL axis.

International immunopharmacology·2026
Same author

Deciphering voltage decay in lithium-rich manganese-based cathodes: the pivotal role of cation mixing-driven structural degradation.

Journal of colloid and interface science·2026
Same author

Quantitative molecular cartography of emergency myelopoiesis reveals conserved modules of hematopoietic activation.

Cell stem cell·2026

Related Experiment Video

Updated: May 31, 2026

Revealing the Ferroptotic Phenotype of Medulloblastoma
04:01

Revealing the Ferroptotic Phenotype of Medulloblastoma

Published on: March 15, 2024

Research Progress on Ferroptosis-Inducing Compounds in Tumor Cells.

Ruiyuan Zhang1,2, Meiyun Xu2, Mansa Li2

  • 1School of Basic Medical Sciences, Jiamusi University, 154007 Jiamusi, Heilongjiang, China.

Die Pharmazie
|May 30, 2026
PubMed
Summary

Ferroptosis, a cell death pathway driven by iron and lipid peroxidation, shows promise in cancer therapy. Overcoming challenges like tumor selectivity and resistance is key for clinical success.

Keywords:
antineoplastic agentsferroptosisglutathione peroxidase 4iron metabolismlipid peroxidationsolute carrier family 7 member 11

Related Experiment Videos

Last Updated: May 31, 2026

Revealing the Ferroptotic Phenotype of Medulloblastoma
04:01

Revealing the Ferroptotic Phenotype of Medulloblastoma

Published on: March 15, 2024

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Ferroptosis is a regulated cell death marked by iron-dependent lipid peroxidation.
  • It plays a crucial role in cancer progression and response to therapy.
  • Dysregulation of iron metabolism and lipid peroxidation pathways are implicated.

Purpose of the Study:

  • To review the molecular mechanisms regulating ferroptosis.
  • To evaluate ferroptosis-inducing compounds and their antitumor effects.
  • To discuss challenges and propose a framework for ferroptosis-based cancer therapies.

Main Methods:

  • Literature review of ferroptosis regulatory networks.
  • Analysis of existing ferroptosis-inducing compounds and their mechanisms.
  • Discussion of clinical translation challenges and future directions.

Main Results:

  • Ferroptosis involves iron-driven reactive oxygen species generation and lipid peroxidation.
  • Compounds targeting iron metabolism, system Xc-, and GPX4 induce ferroptosis.
  • Clinical translation is hindered by selectivity, toxicity, biomarkers, and resistance.

Conclusions:

  • Ferroptosis is a critical, targetable metabolic vulnerability in cancer.
  • Developing context-dependent strategies is essential for effective ferroptosis-based therapies.
  • Addressing translational challenges is crucial for clinical application.